4.8 Letter

Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis

Alessandro Loglio et al.

Summary: This study describes the excellent virological and clinical responses in patients with HDV-related cirrhosis who had contraindications to interferon-based therapies when treated with BLV monotherapy for 3 years.

JOURNAL OF HEPATOLOGY (2022)

Article Virology

The use of humanized mice for studies of viral pathogenesis and immunity

Florian Douam et al.

CURRENT OPINION IN VIROLOGY (2018)

Review Gastroenterology & Hepatology

Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes

Stephan Urban et al.

GASTROENTEROLOGY (2014)